RACINE — President Ronald Reagan in 1983 designated November as the National Alzheimer’s Disease Awareness Month. To recognize this event, Infinite Potential Central, a mental health website ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School ...

Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and ...

In the largest analysis yet of Alzheimer’s disease (AD) gene activity in brain tissue from African American donors, researchers identified more than 400 genes expressed differently in those with AD, ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The foundation will hold a free conference on Feb. 11, highlighting discussions with experts on Alzheimer’s disease, brain ...